Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
The company operates as a telehealth platform connecting patients with independent licensed providers through affiliated medical groups
Access happens through your provider and pharmacy
Is semaglutide covered by any government programs
:max_bytes(150000):strip_icc():focal(749x0:751x2)/Mindy-Kaling-before-and-after-weight-loss-052026-be68f98a02344ad188754613f1570299.jpg)
